Engagement of the T-cell antigen receptor leads to recruitment of phospholipase Cc1 (PLCc1) to the LAT-nucleated signaling complex and to PLCc1 activation in a tyrosine phosphorylation-dependent manner. The mechanism of PLCc1 recruitment and the role of PLCc1 Src homology (SH) domains in this process remain incompletely understood. Using a combination of biochemical methods and real-time fluorescent imaging, we show here that the N-terminal SH2 domain of PLCc1 is necessary but not sufficient for its recruitment. Either the SH3 or C-terminal SH2 domain of PLCc1, with the participation of Vav1, c-Cbl and Slp76, are required to stabilize PLCc1 recruitment. All three PLCc1 SH domains are required for phosphorylation of PLCc1 Y783, which is critical for enzyme activation. These novel findings entailed revision of the currently accepted model of PLCc1 recruitment and activation in T lymphocytes.
Introduction
Ligation of the T-cell antigen receptor (TCR) initiates a cascade of molecular events leading to T-cell activation, cellular proliferation and cytokine production. Proximal events that immediately follow TCR engagement include activation of protein kinases and phosphorylation of multiple enzymes and adaptor molecules (Burack et al, 2002; Samelson, 2002) . The phosphorylation of LAT, a lipid raftassociated adaptor protein, creates docking sites for Srchomology 2 (SH2) domain-containing proteins . Slp76, another adaptor protein phosphorylated following TCR engagement (Wu and Koretzky, 2004) , is recruited to LAT through its constitutive interaction with a small adaptor protein Gads (Liu et al, 2001) . The LAT-Gads-Slp76 complex creates a platform for the recruitment of multiple signaling molecules, including phospholipase Cg1 (PLCg1), the adaptors Grb2 and Nck, the Rho-family GTPase exchange factor Vav, the adaptor with ubiquitin-ligase activity c-Cbl, and the Tec-family kinase Itk (Zhang et al, , 2000 Bunnell et al, 2000; Lewis et al, 2001; Tybulewicz et al, 2003; Wu and Koretzky, 2004) .
Recruitment and activation of PLCg1 is a key step in the T-cell activation process triggered by the TCR (Desai et al, 1990; Bonvini et al, 2003) . The activated enzyme hydrolyzes phosphatidylinositol-4,5-bisphosphate to inositol-1,4,5-trisphosphate (IP 3 ), which stimulates the release of Ca 2 þ from intracellular stores, and diacylglycerol, which activates protein kinase C and RasGRP-dependent signaling pathways (Katan, 1998; Ebinu et al, 2000; Rhee, 2001) . The increase in intracellular free Ca 2 þ concentration triggered by IP 3 plays a crucial role in the induction of numerous T-cell activationassociated responses (Desai et al, 1990) .
Two forms of PLCg have been identified. PLCg1 is ubiquitously expressed, whereas PLCg2 is limited to certain cell types primarily of hematopoietic lineage. T cells express predominantly the PLCg1 form (Katan, 1998) . A common structural feature of all PLCs is a split catalytic domain comprised of two conserved subdomains. In PLCg, these subdomains are separated by a regulatory region, which includes two SH2 domains followed by a single Src-homology 3 (SH3) domain (Katan, 1998; Rhee, 2001) . PLCg1 contains at least five potential sites of tyrosine phosphorylation. Among them only Y775 and Y783, located between the C-terminal SH2 (SH2C) domain and the SH3 domain, are essential for enzyme activation in vivo (Irvin et al, 2000; Rhee, 2001; Serrano et al, 2005) .
Despite the vital function of PLCg1 in T cells and the ubiquitously pivotal role of PLCs in signal transduction in general, the mechanism of PLCg1 activation following TCR engagement is incompletely understood. Several proteins participating in formation of the TCR-proximal signaling complex have been implicated in the regulation of PLCg1 activity. Impaired Ca 2 þ mobilization has been reported in Jurkat cell lines deficient in LAT (Finco et al, 1998; Zhang et al, 2000) , Slp76 (Yablonski et al, 1998) , Vav1 (Cao et al, 2002) , as well as in c-Cbl-deficient (Naramura et al, 1998) or Vav-deficient thymocytes (Reynolds et al, 2002) and Vav-deficient (Costello et al, 1999) or Itk-deficient T cells (Liu et al, 1998; Schaeffer et al, 1999) . LAT has been identified as a primary docking site for PLCg1 following TCR engagement (Zhang et al, 2000; Zhu et al, 2003) . The recruitment of PLCg1 to LAT occurs through specific binding of the N-terminal SH2 (SH2N) domain of PLCg1 to the phosphorylated Y132 (pY132) of LAT (Stoica et al, 1998; Zhang et al, 2000) . Mutations of either SH2N of PLCg1 or Y132 of LAT abrogated PLCg1-LAT association and inhibited PLCg1 phosphorylation and activation (Stoica et al, 1998; Irvin et al, 2000; Zhang et al, 2000; Lin and Weiss, 2001; Paz et al, 2001; Zhu et al, 2003) . No other in vivo binding partners for either LAT-pY132 or the SH2N domain of PLCg1 have been identified in T cells to date.
On the other hand, the SH2C domain of PLCg1 is substantially less selective than the SH2N domain. A chimeric protein consisting of GST fused to the SH2C domain is able to precipitate a range of phosphorylated proteins from activated Jurkat T cells (Stoica et al, 1998; Irvin et al, 2000; Bonvini et al, 2003) . However, it is still unclear which of these proteins interact with PLCg1 via its SH2C domain in vivo.
The loss-of-function mutation of the SH2C domain (R694K) did not affect PLCg1 interaction with LAT and was reported to have a mild to negligible effect on the PLCg1 phosphorylation in Jurkat T cells (Stoica et al, 1998; Irvin et al, 2000) . Yet, expression of SH2C-mutated PLCg1 failed to reverse the impaired IL-2 transcriptional activation in Jurkats expressing low levels of PLCg1 (Irvin et al, 2000) or rescue IP 3 production in PLCg-deficient B cells (DeBell et al, 1999) . The active conformation of PLCg1 involves intramolecular association of the SH2C domain with phosphorylated Y783 (pY783) (Poulin et al, 2005) . Without this association the enzyme is only moderately active. Thus, it has been suggested that, although required for the PLCg1 activity, the SH2C domain is dispensable for PLCg1 recruitment and phosphorylation (Irvin et al, 2000; Bonvini et al, 2003) .
The SH3 domain of PLCg1 has been shown to interact constitutively with c-Cbl in T cells . Several studies have demonstrated that the SH3 domain of PLCg1 can also bind other proline-rich domain-containing proteins, including Slp76 (Yablonski et al, 2001) , Sos (Kim et al, 2000) , Itk (Perez-Villar and Kanner, 1999) and PIKE (Ye et al, 2002) . The significance of these interactions and their occurrence in vivo following TCR engagement remains unclear. Mutation of the SH3 domain has been reported to have no effect on PLCg1 phosphorylation (DeBell et al, 1999) . Moreover, in Jurkat cells expressing low levels of endogenous PLCg1, the SH3-mutated PLCg1 was able to recover impaired IL-2 transcriptional activation more efficiently than wild-type (WT) PLCg1 (Irvin et al, 2000) . It has been hypothesized that the SH3 domain is dispensable for PLCg1 phosphorylation and may negatively regulate PLCg1 activity in T cells (Irvin et al, 2000; Bonvini et al, 2003; Rellahan et al, 2003) .
To summarize, the currently accepted model of PLCg1 regulation in T cells postulates that the SH2N domain of PLCg1 is both necessary and sufficient for its recruitment and phosphorylation following TCR engagement, whereas the SH2C and SH3 domains of PLCg1 are dispensable for this purpose. Our current study contradicts both these propositions. Using a combination of biochemical methods and realtime fluorescent imaging, we show here that the SH2N domain of PLCg1 is necessary but not sufficient for its recruitment to the LAT-nucleated complex. Furthermore, all three SH domains of PLCg1 are required for the efficient phosphorylation and activation of PLCg1 in T cells. In addition, the results of this study contribute new information on the role of other signaling proteins in the process of PLCg1 activation. Thus, we propose a different model of PLCg1 regulation in T cells that can account for both our new findings and previously reported data.
Results
To visualize the recruitment of PLCg1 following TCR stimulation, we have expressed full-length PLCg1 fused to the monomeric version of yellow fluorescent protein (Zacharias et al, 2002 ) (PLCwt-YFP) in WT Jurkat E6 T cells. Our imaging analysis was based on a previously published technique (Bunnell et al, 2002) . In this protocol, T cells were dropped onto a surface coated with a stimulatory monoclonal antibody binding the TCR. This resulted in TCR clustering and recruitment of multiple signaling molecules to the points of contact with the stimulatory surface (Bunnell et al, 2002; Barda-Saad et al, 2005) . Following the initial engagement, the cells spread out on the planar surface over a period of 2-3 min for the Jurkat cells and up to 30 min for human peripheral blood lymphocytes (Bunnell et al, 2002; BardaSaad et al, 2005) . Similar clusters of signaling molecules have recently been observed upon T-cell contact with lipid bilayers containing antigen-MHC complexes (Campi et al, 2005) .
Stimulation of E6 cells stably expressing PLCwt-YFP resulted in formation of PLCg1 clusters within seconds of the initial contact. The cluster formation continued during the cell spreading, then gradually diminished with eventual dissipation within 4-6 min after the beginning of the process ( Figure 1A ; Supplementary video 1). To evaluate whether the clustering of PLCwt-YFP represented its recruitment to signaling complexes, we have created a Jurkat E6 cell line expressing both PLCwt-YFP with either LAT or Slp76 fused with the Cerulean variant of cyan fluorescent protein (Rizzo et al, 2004 ) (LAT-CFP and Slp76-CFP, respectively). It has been shown previously that upon cell stimulation, LAT and Slp76 form clusters that colocalize with the sites of tyrosine phosphorylation, with the TCR and with other molecules recruited to the TCR-proximal signaling complex (Bunnell et al, 2002; Barda-Saad et al, 2005; Campi et al, 2005) . As is evident from Figure 1B and C, the PLCwt-YFP clusters colocalize completely with LAT-CFP and Slp76-CFP, indicating that the PLCwt-YFP clustering represents recruitment of PLCg1 to the LAT-nucleated signaling complex.
To assess the role of its SH domains in the process of PLCg1 recruitment, we have created Jurkat E6 cell lines expressing PLCg1-YFP conjugates bearing the previously described loss-of-function point mutations in the SH3 domain (SH3*-YFP), the SH2C domain (SH2C*-YFP) or the SH2N domain (SH2N*-YFP) (Stoica et al, 1998; Irvin et al, 2000) . The mutation of the SH2N domain abrogated the TCRinduced clustering of PLCg1 ( Figure 1D ), consistent with the notion that the SH2N domain serves as a binding site for LAT and, as such, is necessary for PLCg1 recruitment to the LAT-nucleated complex.
The mutations of either the SH3 or the SH2C domain did not affect the clustering of PLCg1 ( Figure 1D ). It has been suggested that these domains may negatively regulate PLCg1 activity, possibly through binding of c-Cbl, and as such may be responsible for the dissipation of the clusters (Stoica et al, 1998; Bonvini et al, 2003; Rellahan et al, 2003) . Therefore, disruption of both these domains might enhance or prolong the clustering of PLCg1. We have created an additional PLCg1-YFP variant bearing mutations in both the SH3 and the SH2C domains (SH3*SH2C*-YFP). Surprisingly, however, SH3*SH2C*-YFP completely failed to cluster, similar to SH2N*-YFP ( Figure 1D ). The clusters were undetectable at all stages of cell spreading, suggesting that the inhibition of clustering was absolute and not relative to the duration of TCR stimulation. Similar results were obtained using primary murine CD4 þ T cells transiently expressing the To confirm the results obtained using the imaging technique, we evaluated the interaction of the various PLCg1-YFP forms with LAT by precipitating the YFP conjugates with an anti-GFP serum and blotting with an antibody recognizing the phosphorylated Y132 residue (pY132) of LAT. Because maximal PLCg1 phosphorylation is observed by 1 min after stimulation under similar conditions (Houtman et al, 2005) , 1-min stimulation was chosen for this and other biochemical experiments in this study. In agreement with the results described above, phospho-LAT co-precipitated with the clustering conjugates-PLCwt-YFP, SH3*-YFP and SH2C*-YFP (Figure 2A and B). However, no co-precipitation of LAT was observed with the nonclustering SH2N*-YFP and SH3*SH2C*-YFP (Figure 2A and B). This result further supports the conclusion that the observed clusters of PLCg1-YFP ( Figure 1 ) represent recruitment of PLCg1 to LAT and that the concomitant mutation of both the SH3 and SH2C domains block this recruitment. These results indicate that contrary to the currently accepted model, the SH2N domain alone is not sufficient for the PLCg1 recruitment to the LAT-nucleated cluster. Although the SH3 and the SH2C domains, taken separately, are dispensable for the PLCg1 recruitment, at least one of them is required in combination with the SH2N domain to maintain the association of PLCg1 with activated LAT.
It has been reported previously that mutations of either the SH3 or SH2C domains had little or no effect on the general tyrosine phosphorylation of PLCg1 (Stoica et al, 1998 ; DeBell Irvin et al, 2000) . Yet, these findings did not correlate well with the functional impact of the mutations on downstream signaling. PLCg1 contains several tyrosine residues that can be phosphorylated upon stimulation. However, only two of them, Y783 and the recently discovered Y775, are necessary for enzyme activation (Irvin et al, 2000; Rhee, 2001; Serrano et al, 2005) . Therefore, we have assessed the effect of the SH domain mutations on phosphorylation of these critical tyrosine residues using specific antibodies binding these phosphorylated sites-anti-pY783 ( Figure 2C and D) and anti-pY775 (not shown). The ability to distinguish the endogenous PLCg1 and the PLCg1-YFP conjugates as separate bands on Western blots provided a clear advantage for analyzing these results. Comparison between the level of phosphorylation of the YFP conjugates with that of the endogenous PLCg1 in the same cells allowed more accurate assessment of the effect produced by the mutants and prevented skewed results because of a possible general effect of the mutants on the stimulation. The results clearly demonstrate ( Figure 2C and D) that upon stimulation PLCwt-YFP is phosphorylated to the same extent as endogenous PLCg1, ruling out the possibility of YFP interfering with phosphorylation. However, the loss-of-function mutation in either of the three SH domains strongly inhibits phosphorylation of Y783. Moreover, despite the fact that SH3*-YFP and SH2C*-YFP are recruited to the LAT-nucleated signaling complex, Y783 phosphorylation in these mutants is inhibited more severely than that in SH2N*-YFP, which is not recruited (Figure 2C and D) . Virtually identical phosphorylation pattern was obtained using anti-pY775 (not shown). Note that the mutations did not interfere with the ability of the proteins to act as a substrate for tyrosine kinases, as pervanadate stimulation induced Y783 phosphorylation in all PLC-YFP conjugates at levels comparable with those obtained in endogenous PLCg1 (Supplementary Figure S1) . These results suggest that both the SH3 and SH2C domains are indispensable for the efficient phosphorylation and activation of PLCg1 and that PLCg1 recruitment to the signaling complex alone is not sufficient for this purpose.
The deleterious effect of the SH domain mutations on recruitment and activating phosphorylation of PLCg1 might be explained by disruption of PLCg1 interactions with other signaling proteins normally mediated by these domains. Precipitation of PLCwt-YFP from the stimulated E6 cells reveals four clear bands of tyrosine-phosphorylated proteins co-precipitating with PLCg1 ( Figure 3A , second lane). The 36-38 kDa band has already been identified as LAT (Figure 2A ). The other three bands correspond in sizes to Slp76, Vav1 and c-Cbl, all of which have been implicated in the PLCg1 regulation in T cells (Naramura et al, 1998; Yablonski et al, 1998; Costello et al, 1999; Cao et al, 2002; Reynolds et al, 2002; Rellahan et al, 2003) . Application of antibodies specific to Slp76, phosphorylated Vav1 (pVav1) or phosphorylated c-Cbl (pc-Cbl) confirmed the identity of these bands ( Figure 3B ). Mutation of any of the SH domains abrogated co-precipitation of PLCg1 with Slp-76 ( Figure 3B ). Consistent with the previously reported constitutive interaction between PLCg1 and c-Cbl mediated via the SH3 domain of PLCg1 , co-precipitation of these two proteins was completely blocked in the PLCg1 mutants lacking a functional SH3 domain ( Figure 3B and C). Precipitation of Vav1 was substantially inhibited with either SH3*-YFP or SH2C*-YFP and was undetectable with either SH2N*-YFP or SH3*SH2C*-YFP ( Figure 3B and D) . These results suggest that the SH domains of PLCg1 mediate its interactions with Slp76, Vav1 and c-Cbl. The loss of these interactions might account for the impaired recruitment and phosphorylation of the SH domain mutants.
Co-precipitation does not necessarily indicate direct interaction between the protein molecules. Therefore, we have applied the fluorescence resonance energy transfer (FRET) technique to address this issue. As FRET can occur between fluorescent species separated no further than B10 nm, detection of FRET between two protein molecules strongly suggests their direct interaction. Unfortunately, we have not been able to detect FRET between full-length PLCg1-YFP and either LAT-CFP or Slp76-CFP, although direct interaction between PLCg1 and LAT is well documented (Stoica et al, 1998; Zhang et al, 2000) . This may be due to the size and structure of PLCg1, which places YFP at a greater distance from the interacting proteins than is allowed for FRET. Therefore, we have created a truncated version of PLCg1-YFP (PLCs-YFP) by removing the C-terminal part of the PLCg1 catalytic domain, thereby placing YFP closer to the SH domains of PLCg1. Figure 4 demonstrates that PLCs-YFP is recruited to the signaling clusters similarly to PLCwt-YFP. Furthermore, a FRET signal has been detected between PLCs-YFP and either LAT-CFP, c-Cbl-CFP, Vav1-CFP or Slp76-CFP (Figure 4A-D) suggesting direct interaction between these proteins. Note that FRET between PLCs-YFP and c-Cbl-CFP, in contrast to the other proteins, is not limited to the clusters, which is likely due to the constitutive nature of the PLCg1 and c-Cbl interaction. Interestingly, the C-terminus labeled Slp76 (Slp76-CFP) exhibited substantially lower FRET efficiency with PLCs-YFP than its N-terminus labeled counterpart (CFP-Slp76) ( Figure 4D and E) . This sensitivity of the observed FRET efficiency to the structural variations within the protein complex suggests that the obtained FRET signal reflects actual protein interactions and is not merely due to high protein density within the cluster. Predictably, no significant FRET was observed between LAT-CFP and PLCs-YFP mutated at the SH2N domain of PLCg1 ( Figure 4F ).
To further evaluate the role of Slp76 and Vav1 in PLCg1 recruitment, we expressed PLCg1-YFP conjugates in cells deficient in either of these proteins. Expression of PLCwt-YFP in the Slp76-deficient Jurkat J14 cells revealed strong inhibition of PLCg1 recruitment to the signaling clusters ( Figure 5A ). This result was unexpected, as normal co-precipitation of PLCg1 with LAT in the J14 cells has been previously shown (Yablonski et al, 1998) . In the course of an independent study, we have discovered that the expression of c-Cbl in the J14 cells used in our experiment is substantially reduced compared to those observed in E6 cells. To assess whether the reduced level of c-Cbl can account for the impaired PLCg1 recruitment, we have created a J14 cell line expressing c-Cbl-CFP (J14-Cbl) at a level similar to the level of c-Cbl in E6 cells (Supplementary Figure S2) . Reconstitution of J14 cells with c-Cbl restored normal clustering of PLC-YFP and SH2C*-YFP ( Figure 5B ). Colocalization of PLCg1 and c-Cbl clusters is worth noting. However, c-Cbl-CFP was unable to rescue the clustering of SH3*-YFP ( Figure 5B ) observed in the WT Jurkats ( Figure 1D ). These results suggest that the SH3-mediated interaction of PLCg1 with c-Cbl stabilizes PLCg1 recruitment to the signaling complex. Although reconstitution of the J14 cells with c-Cbl restored recruitment of PLCg1, it was unable to rescue PLCg1 activity ( Figure 5C ). Yet, reconstitution of J14 cells with Slp76 (J14-Slp) restored calcium mobilization ( Figure 5C ) and PLCwt-YFP clustering (not shown) in these cells. Therefore, in the presence of Slp76, c-Cbl is either redundant for PLCg1 activation or the low levels of c-Cbl present in J14 cells are sufficient to maintain its functionality under these conditions.
To differentiate between these two possibilities, we have transiently expressed PLCwt-YFP in CD4 þ T cells derived from c-Cbl knockout (KO) mice. Contrary to the results obtained in WT CD4 þ T cells ( Figure 1E ), PLCwt-YFP clustering was abolished in c-Cbl-deficient T cells, despite normal TCR stimulation as indicated by multiple phospho-tyrosine clusters ( Figure 5D ). In addition, it has been shown previously that calcium elevation in T cells from c-Cbl KO mice is strongly inhibited (Chiang et al, 2004) . These results together indicate that c-Cbl at some level is required for PLCg1 recruitment and activation. Impaired calcium mobilization has also been demonstrated in Vav1-deficient T cells (Costello et al, 1999; Cao et al, 2002; Reynolds et al, 2002) . However, the general tyrosine phosphorylation of PLCg1 was not affected by Vav1 deficiency in Jurkat T cells (Reynolds et al, 2002) . Because the total tyrosine phosphorylation does not necessarily reflect phosphorylation of the critical Y783 residue, we have evaluated phosphorylation of PLCg1 in the Vav1-deficient Jurkat J.vav cells using an anti-pY783 antibody. As can be seen in Figure 6A , phosphorylation of Y783 in J.vav cells is greatly reduced compared to E6.1 cells. Predictably, the calcium response in J.vav cells is strongly inhibited ( Figure 6B) .
Comparison between tyrosine-phosphorylated proteins that co-precipitate with PLCg1 in J.vav versus E6 cells reveals a conspicuous absence of a band corresponding to Slp76 in precipitate, obtained from the former ( Figure 6C) . Interestingly, the amount of pc-Cbl co-precipitated with PLCg1 in J.vav is substantially greater than that obtained in E6 cells. These results suggest that Vav1, and possibly Slp76, may compete with c-Cbl for PLCg1 binding.
Expression of PLCwt-YFP in J.vav cells demonstrated that in the absence of Vav1, PLCg1 was still recruited to the signaling clusters ( Figure 6D ). However, unlike the result we observed in WT Jurkats (Figure 1D ), both the SH3*-YFP and SH2C*-YFP failed to cluster in J.vav cells ( Figure 6D ). Taken together, these data suggest that Vav1 plays an important role in both recruitment and activation of PLCg1.
Discussion
Stimulation of the TCR leads to recruitment of PLCg1 to the TCR-proximal signaling complex, followed by PLCg1 phosphorylation and activation (Zhang et al, , 2000 Bonvini et al, 2003) . The hallmark of PLCg1 recruitment is its association with LAT through binding of the PLCg1 SH2N domain to pY132 of LAT (Stoica et al, 1998; Zhang et al, 2000) . In this study, we show that the PLCg1 SH2N domain is not sufficient for the recruitment of the enzyme to the LATnucleated signaling complex. Although mutation of either the SH2C or SH3 domain of PLCg1 separately does not interfere with its binding to LAT, mutation of both of these domains abolishes PLCg1 recruitment and activation (Figures 1D and E and 2C and D) .
These results suggest that although the SH3 and SH2C domains of PLCg1 do not bind directly to LAT, they can participate in the stabilization of the PLCg1-LAT association via other proteins in the LAT-nucleated signaling complex. These proteins can bind the PLCg1 SH3 and SH2C domains and bridge between PLCg1 and LAT. Either of the SH3 or SH2C domains can sufficiently stabilize the PLCg1-LAT association without participation of the other. However, functional elimination of both of them or, alternatively, mutation of two or all three distal pYs of LAT (Zhang et al, 2000; Lin and Weiss, 2001; Paz et al, 2001; Zhu et al, 2003) , destroys the 'bridge' and abolishes PLCg1 association with LAT.
We also show that recruitment of PLCg1 to the LATnucleated complex does not necessarily result in PLCg1 activation. It has been proposed earlier that the SH3 and SH2C domains are dispensable for PLCg1 phosphorylation, because an application of a general anti-pY serum did not reveal a substantial decrease in the tyrosine phosphorylation of the SH3* and SH2C* mutants (Stoica et al, 1998; DeBell et al, 1999; Irvin et al, 2000; Bonvini et al, 2003) . However, the data presented here provide evidence to the contrary. Using site-specific anti-pY antibodies, we show that phosphorylation of Y783, which is critical for PLCg1 activation, is strongly inhibited in the SH3* and SH2C* mutants ( Figure 2C  and D) . Moreover, the Y783 phosphorylation of the SH2N* mutant, which is not recruited to LAT, appears to be more efficient than that of the SH3* or the SH2C* mutants despite seemingly normal recruitment of these two proteins to the signaling complex. Similar results were obtained for the Y775 site. Thus, in addition to their role in stabilization of the PLCg1-LAT association, the SH3 and SH2C domains are essential for efficient phosphorylation of Y783 and Y755. It is possible that the collaborative engagement of the SH3 and SH2C domains confers a conformational change exposing Y783 and Y755, otherwise not readily accessible for phosphorylation. Mutation in either the SH3 or SH2C domain results in a nonproductive recruitment of PLCg1. Yet, this recruitment may still be sufficient to induce phosphorylation of PLCg1 tyrosine residues other than Y783 or Y755, which may explain seemingly unaffected phosphorylation of the SH3* and SH2C* mutants observed with a general anti-pY serum ( We confirm here that, in addition to LAT, at least three tyrosine-phosphorylated proteins-Slp76, c-Cbl and Vav1-co-precipitate with PLCg1 from stimulated Jurkat T cells (Figure 3 ). This co-precipitation is affected by mutations in the PLCg1 SH domains ( Figure 3B ). The FRET data indicate that PLCg1 bind these proteins directly (Figure 4) . Together with previously reported evidence (Finco et al, 1998; Liu et al, 1998; Naramura et al, 1998; Yablonski et al, 1998; Costello et al, 1999; Schaeffer et al, 1999; Zhang et al, 2000; Cao et al, 2002; Reynolds et al, 2002) , these results suggest that Slp76, c-Cbl and Vav1 are the likely candidates for the proteins participating in PLCg1 activation within the LATnucleated signaling complex. It has been demonstrated that c-Cbl binds constitutively to the PLCg1 SH3 domain . In agreement with these findings, we show here that co-precipitation of PLCg1 with c-Cbl critically depends on the functional integrity of the PLCg1 SH3 domain ( Figure  3B and C). Moreover, recruitment ( Figure 5 ) and activation (Chiang et al, 2004) of PLCg1 is strongly inhibited in c-Cbldeficient T cells. These data suggest that c-Cbl may facilitate and stabilize recruitment of PLCg1 through their constitutive SH3-dependent interaction.
It has been shown that Slp76 is essential for PLCg1 Y783 phosphorylation and activation (Yablonski et al, 1998; Gonen et al, 2005) . We show here that mutation in any of the three SH domains of PLCg1 results in a complete loss of PLCg1-Slp76 co-precipitation ( Figure 3B) . Interestingly, the loss of PLCg1-Slp76 co-precipitation remarkably coincides with inhibition of the PLCg1 Y783 phosphorylation (Figures 2C and 3B and elsewhere: Yablonski et al, 1998; Reynolds et al, 2002; Gonen et al, 2005) . The N-terminal pY residues of Slp76 have been identified as a binding site for the SH2 domain of the Tec-family kinase Itk, which can phosphorylate PLCg1 (Bunnell et al, 2000; Lewis et al, 2001) . Thus, the key function of Slp76 in PLCg1 activation may lie in the recruitment of Itk to the signaling complex, whereas the SH3 and SH2C domains of PLCg1 jointly participate in the formation of a productive interaction between PLCg1 and the Slp76-Itk pair.
The N-terminal pY residues of Slp76 also provide a binding site for Vav1 (Fang and Koretzky, 1999 ) with a possible formation of a Slp76-Itk-Vav1 complex (Dombroski et al, 2005) . Our results suggest that Vav1 facilitates association between PLCg1 and Slp76, corroborating similar observations reported previously (Reynolds et al, 2002) . Both the SH2C and SH3 domains of PLCg1 mediate PLCg1-Vav1 association. This function of Vav1 may underlie its indispensability for PLCg1 phosphorylation and activation ( Figure 6A and B and elsewhere; Costello et al, 1999; Cao et al, 2002; Reynolds et al, 2002) .
To summarize the data shown and cited above, we propose the following model for the recruitment and activation of PLCg1 in T cells (Figure 7) . TCR engagement leads to recruitment of PLCg1 to the LAT-nucleated complex through binding of the PLCg1 SH2N domain to the pY132 residue of LAT. However, this binding is not sufficient to maintain the PLCg1-LAT association. Either the SH3 or SH2C domain of PLCg1 must stabilize this association through binding to other proteins in the LAT-nucleated signaling complex. Vav1, c-Cbl and Slp76 bridge between the PLCg1 SH3 and SH2C domains and LAT. Although only one of these domains is required for stabilization of the PLCg1-LAT association, both the SH3 and SH2C domains together are necessary for an efficient presentation of PLCg1 Y783 and Y755 to the activating kinase, probably Itk. Elimination of either of these domains or, alternatively, elimination of either Slp76 or Vav1 partially destabilizes the PLCg1-LAT complex and results in a nonproductive recruitment of PLCg1.
Materials and methods

Antibodies
Mouse anti-CD3e, anti-CD28, anti-CD4, human anti-CD3 HIT3a and anti-CD3 PE-Cy5 were purchased from Pharmingen. Anti-phosphotyrosine 4G10, anti-c-Cbl 7G10, goat anti-mouse IgG-HRP, goat antirabbit IgG-HRP were from Upstate Biotechnology. Anti-LAT-pY132, anti-PLCg1-pY783, anti-Vav1-pY160 were from Biosource. AntiSlp76 was from Antibody Solutions. Anti-c-Cbl-pY774 was from Cell Signaling Technology. Anti-PLCg1 was from Santa Cruz Biotechnology. Anti-GFP was from Roche. Anti-GAPDH was from Biodesign. Anti-PLCg1-pY775 was provided by Dr BL Rellahan (Division of Monoclonal Antibodies, US Food and Drug Administration, Bethesda, MD).
Expression vectors and plasmids
The bovine PLCg1 cDNA was provided by Dr E Bonvini (Division of Monoclonal Antibodies, US Food and Drug Administration, Bethesda, MD). The rat Vav1 cDNA was provided by Dr J Rivera (Section on Chemical Immunology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD). LAT-CFP, Slp76-CFP and c-Cbl-CFP were generated from previously described constructs (Donovan et al, 1996; Bunnell et al, 2002; Barda-Saad et al, 2005) . The monomeric YFP plasmid was created from pEYFP-N1 (Clontech) by A206K substitution (Zacharias et al, 2002) . The Cerulean CFP plasmid was created from pECFP-N1 (Clontech) by A206, S72A, Y145A and H148D substitutions (Zacharias et al, 2002; Rizzo et al, 2004) . The resultant YFP and CFP variants were used to create all fluorescent conjugates by standard methods. Truncated PLCg1-YFP vector (PLCs-YFP) encodes for PLCg1 (1-933) fragment followed by YFP. Point mutations were introduced using a QuikChange II XL sitedirected mutagenesis kit (Stratagene). The constructs were cloned into either pMSCVhyg or pMSCVneo (Clontech) to create retroviral expression vectors. All constructs were verified using DNA sequencing.
Vector expression and generation of stable cell lines
Jurkat cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum. The recombinant DNA was introduced into the cells using retroviral infection. The retroviral expression vectors and pVSV-G (Clontech) were cotransfected into GP2-293 packaging cells (Clontech) using Lipofectamine 2000 (Invitrogen). After 48 h, the virus-containing medium was removed from the packaging cells and mixed with Jurkat cells. The medium was replaced with the regular growth medium after 24 h and an appropriate selection medium was added 72 h post-infection. The cells were sorted and those expressing fluorescent conjugates at the levels comparable with the corresponding endogenous proteins in the WT Jurkats were collected and expanded. Protein expression was monitored at multiple time points using flow cytometry and Western blotting. TCR expression level was monitored using immunostaining with anti-CD3 PE-Cy5 followed by flow cytometry.
Transfection of murine T cells
Mice used in this study were on a C57BL/6 background. C-Cbl KO (Cbl À/À ) mice were described previously (Chiang et al, 2004) . CD4 þ T cells from lymph nodes were purified by magnetic bead separation as previously described (Sommers et al, 2005) . Cells were transfected with PLCg1-YFP using AMAXA electroporator and AMAXA kit for primary murine T cells and used 48 h posttransfection.
Confocal microscopy
The spreading assays were performed as described previously (Bunnell et al, 2002; Barda-Saad et al, 2005) . Briefly, chambered coverslips (LabTek) were coated overnight at 41C with either the stimulatory antibody anti-CD3e HIT3a (10 mg/ml) or mouse antiCD3e, anti-CD28 and anti-CD4 (10 mg/ml each). The cells were seeded onto coated coverslips containing imaging buffer (RPMI 1640 without phenol red, 10% fetal calf serum, 20 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid). Some cells were fixed at different time points with 2-4% paraformaldehyde in phosphate-buffered saline. Immunostaining was performed as described previously . Fluorescent images were acquired on a LSM510 confocal system (Carl Zeiss) using a Â 63 Plan-Apochromat objective (Carl Zeiss). A hot air blower (Nevetec) was used to maintain live samples at 371C, and fine adjustments were made with a digital probe monitoring the buffer temperature in the chamber. The acquired images were extracted with the LSM browser (Carl Zeiss), cropped and composed into figures with Adobe Photoshop. The images were pseudo-colored as following, CFP-cyan, YFP-yellow, pY-magenta. No image enhancement procedures have been performed.
FRET was measured by the donor-sensitized acceptor fluorescence technique as described previously . Briefly, three images were acquired for each set of measurements: YFP excitation/YFP emission image (YFP channel); CFP excitation/ CFP emission image (CFP channel) and CFP excitation/YFP emission image (FRET channel). A set of reference images was acquired from single-labeled CFP or YFP-expressing cells for each set of acquisition parameters and a calibration curve was derived to allow elimination of the non-FRET components from the FRET channel. The FRET efficiency was calculated on a pixel-by-pixel basis using the following equation: 
